“roche” Archives

in
Entry Author Date Location
Hurry and Save 20 Percent on NY Life Sciences 2021 12/08/16 New York
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Arrowhead Chief Scientific Officer David Lewis Among 34 Laid Off 12/01/16 Wisconsin
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
At NY Life Sci 2021, Yancopoulos, Dunn & More to Ponder NYC’s Bio Future 10/19/16 New York
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
New Rockefeller Prez Takes Stock of “Wildly Underdeveloped” NY Bio Scene 09/27/16 New York
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
In Battle Between Promega and Shareholders, Linton Heads to Court 08/02/16 Wisconsin
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
Arrowhead Pharmaceuticals CEO on Name Change, Clinical Trial Progress 07/21/16 Wisconsin
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
3 Things You (Probably) Don’t Know about Indiana Innovation 07/05/16 Indiana
Eleven Bio, Still Breathing, Sells Eye Drug to Roche 06/13/16 Boston
Alexandria Sets up Incubator, $25M Seed Fund For NY Bio Startups 06/08/16 New York
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
In Immuno-Oncology’s Latest Win, FDA OK’s Genentech Drug 05/18/16 San Francisco
Armed With Patent, Foundation Med Sues Diagnostic Rival Guardant 05/18/16 Boston
Stemina Gives Update on Autism Study, Tweaks Business Structure 05/10/16 Wisconsin
Probing Gut Microbiome, Second Genome Nabs $43M To Push Colitis Drug 04/20/16 San Francisco
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy 03/15/16 Boston
Failed Alzheimer’s Drug To Get Another Shot, If Investors Pony Up 03/11/16 Boston
On Comeback Trail, Exelixis Reels In $200M Deal For Cancer Drug 02/29/16 San Francisco
West Coast Bio Roundup: CRISPR Patent, HCV Data, Verily Digs & More 02/19/16 San Francisco
Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs 02/02/16 Boston
Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug 01/27/16 Boston
Page 1 of 18 next page »